REDCap Cloud to harmonise real-world evidence and trial data with new platform

The platform’s architecture allows it to handle everything from small single-site pilot trials to complex multi-phase programs.

News Provided: September 16th, 2025

REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence with clinical study data within a single system.

The REDCap Cloud 2.0 platform is designed to meet the intricate data requirements of large-scale research and paves the way for the integration of AI, which is expected to transform research methods and analysis in life sciences.

The company noted that real-world evidence and data, derived from various sources such as patient forms, electronic health records, and wearable devices, are increasingly influential in research.

However, this data often suffers from inconsistencies, quality issues, and comes in various formats.

Research teams are burdened with the task of rectifying errors, filling in missing details, and manually transferring data between different systems.

REDCap Cloud is said to address these issues, providing researchers with an instantaneous view of study performance.

Its automated data quality checks, anomaly identification, and issue triage systems enable the quick production of datasets ready for analysis, complete with auditable data lineage.

REDCap Cloud 2.0 is said to offer universal trial support, which allows the platform’s architecture to handle everything from small single-site pilot trials to complex multi-phase programmes and vast registries. This flexibility is maintained without the need to change tools during the trial.

The platform simplifies the process of implementing protocol amendments, allowing operations to continue without interruption or compliance risks, thereby decreasing the expenses and timeline issues associated with amendments.

With the addition of analytics capabilities built directly into REDCap Cloud, trial teams can now work from a singular, reliable data source. This integration is expected to speed up clinical development and improve collaboration among international research stakeholders.

REDCap Cloud COO Dave Sunderhaft said: “For the first time, sponsors can see how a study is performing clinically in near real-time, compressing the ‘white space’ between data collection and scientific review and enabling teams to accomplish in days what previously took months.

“REDCap Cloud 2.0 is not just an upgrade, it’s the platform our industry has been waiting for to unify all clinical data on a standards-based foundation, and proving it at enterprise scale.”

Originally published on Clinical Trials Arena, Sept 16th, 2025

About REDCap Cloud (nPhase, Inc.)
REDCap Cloud is an enterprise-grade clinical research data platform that integrates clinical trial and real-world evidence into a unified data layer for clinical decision-making. Purpose-built for life sciences with a foundation in security, compliance and AI-ready infrastructure, researchers can now unlock the full potential of their data.REDCap Cloud is redefining how research data is captured, harmonized, and analyzed across the global healthcare ecosystem.
For more information visit www.redcapcloud.com.